VRG Technologies, Inc.


 Home Up Products Patents Investing Press Releases Contacts



Vector Research - Global Technologies.


Genomics is quietly transforming the pharmaceutical industry. Companies are moving from drug discovery and development based on medicinal chemistry to designing and
developing drugs based on information provided by genomics. Virtually all the major pharmaceutical houses have formed partnerships with genomics firms that began to emerge in the early 1990s or have created genomics divisions in-house. As little as two years ago, there were only dozen or so firms in the genomics industry. In 1999, there were estimated to be more than 200 companies worldwide that list genomics as one of
their businesses.

According to a soon-to-be-released BUSINESS COMMUNICATIONS CO., INC. study RB-142 The Genomics Revolution, the market for genomics-based products and services was estimated at $2.2 billion in 1999. Growing at an average growth rate of 30.1% during the 5-year forecast period, this market is expected to reach $8.2 billion by 2004. 

Of the two applications markets for genomics-based products and services, the research sector--which in 1999 comprised gene sequencing, polymorphism analysis and gene expression--represented the greater part of the market. It will grow at an AAGR of 27.2% over the next five years and is expected to total $3.7 billion by 2004.

However, the applied sector--which in 1999 comprised viral genotyping, diagnostics and disease management--will begin to overtake the research market and is projected to reach approximately
$4.5 billion and represent about 55% of the total market in 2004. This market is growing at an outstanding rate of 33.2% on average in the next five years.

Genomics allows greater efficiency in identifying therapeutic targets by determining which genes are responsible for the creation or enabling of disease processes, how these genes control these
processes and what might be done to stop them. Products provided by genomics firms include not only databases but specialized software to search the databases. Besides databases, another
genomics product is the DNA (deoxyribonucleic acid) biochip (also called the DNA microassay or DNA chip) which is able to analyze hundreds of samples simultaneously with nucleic acid probes
placed on glass wafer.

($ Millions)
  1999 2004 AAGR % 
Research  1,120 3,720 27.2
Applied 1,063 4,440 33.2
Total 2,183 8,160 30.1

RB-142 The Genomics Revolution

Published: April 2000

Data and analysis provided courtesy of BUSINESS COMMUNICATIONS COMPANY, INC., 25 Van Zant Street, Norwalk, CT 06855,  Telephone: (203) 853-4266; ext. 309,  Email: publisher@bccresearch.com

Back Home Up Next 


VRG Technologies, Inc.

Last Modified : 12/10/01 07:09 PM

Copyright 2001